DeepLook

New Haven, United States Founded: 2019 • Age: 7 yrs
Digital precision decision-making tools for medical diagnosis

About DeepLook

DeepLook is a Healthcare company based in New Haven (United States) founded in 2019 by Steve Schwadron and Greg Belanger. Digital precision decision-making tools for medical diagnosis. DeepLook has raised $5.75 million across 3 funding rounds from investors including Xcellerant Ventures, OKG Capital and Connecticut Innovations. Its chief executive, as recorded, is Ken Boulange. DeepLook offers products and services including DL Precise. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include AIdoc, HeartFlow and Lantheus; 2 of its 3 listed competitors have raised funding.

Company details

DeepLook was founded in 2019 in New Haven, United States, within the medical technology sector. Software solutions such as DL Precise are provided for the automated measurement and analysis of medical images, including mammograms, CT scans, and ultrasounds. Tumors are characterized to support treatment planning, while growth rates and shrinkage timelines are calculated based on longitudinal data. Operations focus on aiding healthcare professionals in diagnostic precision.

  • Headquarters New Haven, United States
  • Founders Steve Schwadron, Greg Belanger
  • Sectors
    Healthcare
  • Website deeplookmedical.com
  • Social LinkedIn
Key Metrics
  • Total Equity Funding
    $5.75M (USD)

    in 3 rounds

  • Latest Funding Round
    $2.52M (USD), Series A

    Sep 2024

  • Investors

Products & Services of DeepLook

DeepLook offers a comprehensive portfolio of products and services, including DL Precise.

DL Precise
Imaging Software

Enhances radiology images for accurate lesion detection and diagnosis

Funding Insights of DeepLook

DeepLook has successfully raised a total of $5.75M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.52 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $5.75M
  • Total Rounds 3
  • Last Round Series A β€” $2.52M
  • First Round $1.54M

    (Jan 2023)

  • Investors Count 6

All 3 funding rounds of DeepLook with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2024$2.52MSeries A–Xcellerant Ventures
Feb 2024$1.7MSeed–Connecticut Innovations, Tidal River
Jan 2023$1.54MSeed––
–
Valuation history

6 investors in total: 6 institutional.

Investors in DeepLook

DeepLook has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Xcellerant Ventures, OKG Capital and Connecticut Innovations.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Xcellerant Ventures is focused on funding healthcare innovation.
xcellerantventures.com
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
ctinnovations.com
A women-led fund is operated to support early-stage companies.
2020tidalriverct.comUnited States
A network for angel investors and entrepreneurs is provided.
angelinvestorforum.comUnited States
werthventures.com
Premium access

Investor details for DeepLook

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of DeepLook

6 people are tracked at DeepLook (6 in leadership).

NameRoleGroup
Steve Schwadron
Co-FounderLeadership
Greg Belanger
Co-FounderLeadership
Ken Boulange
CEOLeadership
Alice Raia
Chief Technology OfficerLeadership
David Dahn
CFOLeadership
Marissa Fayer
Chief Executive OfficerLeadership
Premium access

Complete people profiles for DeepLook

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of DeepLook

3 dated milestones of DeepLook across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded DeepLook is founded.
  2. Funding First funding round of $1.5M.
  3. Funding Latest funding round, Series A, of $2.5M.

Competitors of DeepLook

DeepLook has 3 listed competitors in our database, 2 of them funded. They include AIdoc, HeartFlow and Lantheus.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
aidoc.com2016New York, United States$424.5M
AI-based single-screen system is provided to streamline medical imaging.
heartflow.com2007Redwood, United States$936.05M428
Cardiovascular diagnostics are provided using CT scans and analytics.
lantheus.com2008Billerica, United States834
Developer of diagnostic imaging agents and targeted therapeutics
Premium access

Detailed competitors of DeepLook

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of DeepLook

The website of DeepLook (deeplookmedical.com) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▼ 9.4% vs previous month

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as DeepLook (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Deeplook

Premium access

Complete news archive for DeepLook

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about DeepLook

DeepLook was founded in 2019 and raised its 1st funding round 4 years after it was founded.

DeepLook is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.

Ken Boulange is the CEO of DeepLook, as recorded in our data.

DeepLook is a funded company, having raised a total of $5.75M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.54M, raised on Jan 2023.

DeepLook was founded in 2019 in New Haven, United States, within the medical technology sector. Software solutions such as DL Precise are provided for the automated measurement and analysis of medical images, including mammograms, CT scans, and ultrasounds. Tumors are characterized to support treatment planning, while growth rates and shrinkage timelines are calculated based on longitudinal data. Operations focus on aiding healthcare professionals in diagnostic precision.

DeepLook's top competitors include AIdoc, HeartFlow and Lantheus.

DeepLook offers DL Precise.

DeepLook has 6 investors. Key investors include Xcellerant Ventures, OKG Capital, Connecticut Innovations, Tidal River, and Angel Investor Forum.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available